Abstract | PURPOSE: To evaluate the implantation of Artisan/Verisyse phakic intraocular lenses (pIOLs) (Advanced Medical Optics) as an effective and safe method for the correction of high myopia. SETTING: Department of Ophthalmology, John A. Moran Eye Center, University of Utah Medical Center, Salt Lake City, Utah, USA. METHODS: This retrospective outcomes trial examined the implantation of Artisan/Verisyse pIOLs in 85 highly myopic eyes (mean spherical equivalent -12.2 diopters). Patients were followed for 2 years and examined postoperatively at 1,6,12, and 24 months. Data collected included best spectacle-corrected visual acuity (BSCVA), uncorrected visual acuity (UCVA), corneal endothelial cell density, and adverse events. RESULTS: Six months postoperatively, 5 (7%) eyes lost 1 line of the BSCVA; no eye lost 2 or more lines. The UCVA was better than 20/40 in 83% of eyes and better than 20/25 in 32%. Endothelial cell density decreased by 3.3% and 6.5% over the 1-year and 2-year intervals, respectively. Glare and halos, the most common complications of surgery, were reported by 6% of patients at 1 month and by 3% at 2 years. CONCLUSION: Implantation of the Verisyse/Artisan pIOL yielded accurate refractive results with acceptable safety in highly myopic eyes.
|
Authors | Majid Moshirfar, Huck A Holz, Don K Davis |
Journal | Journal of cataract and refractive surgery
(J Cataract Refract Surg)
Vol. 33
Issue 8
Pg. 1392-7
(Aug 2007)
ISSN: 0886-3350 [Print] United States |
PMID | 17662430
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Topics |
- Adult
- Anterior Chamber
(surgery)
- Cell Count
- Endothelium, Corneal
(pathology)
- Female
- Follow-Up Studies
- Humans
- Iris
(surgery)
- Lens Implantation, Intraocular
(methods)
- Lens, Crystalline
(physiology)
- Lenses, Intraocular
- Male
- Middle Aged
- Myopia
(surgery)
- Postoperative Complications
- Treatment Outcome
- Visual Acuity
|